Sarasota biotech firm develops new prototype for treating concussions

A Sarasota medical technology has completed a new prototype. Oragenics created an automated intranasal device for those who have suffered concussions and are in an acute phase of their injury.

“We are excited about this new automated technology as it allows us to treat the full range of concussive injuries,” Oragenics President Michael Redmond says in a statement. “Given the early mental alterations many concussed patients experience, we aim to provide them the best drug delivery route to improve their clinical outcomes.”

About 69 million concussions are reported worldwide each year, and 10% of patients with concussions become unconscious, while many others experience an altered mental state that can include confusion and short-term memory loss, according to a statement from Oragenics. That makes it difficult to administer medicine, which is why automated technology is key.